web analytics

 

 

 

 

Treatment of Neurological disorders, using IVIg, has become the standard of care in many Neurological Practices throughout the United States. Recent studies have determined that IVIg was well tolerated in long term use and was as effective as Plasmapheresis in treating various neurological conditions.

 

In a review done by C. M. Wiles, “Intravenous Immunoglobulin in Neurological Disease: A Specialist Review”, it was determined that the following neurological diseases respond to the use of high dose IVIg as a primary treatment: 1a) Evidence obtained from meta – analysis of randomized controlled clinical trial, 1b) Evidence obtained from at least one randomized controlled trial, III) Evidence obtained from well designed, non-experimental descriptive studies such as: comparative studies, correlation studies, and case studies.

 

The Neurological conditions are as follows:

 

  • Myasthenia Gravis (Acute Severe or Deteriorating) – 1b
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Lambert – Eaton Syndrome – 1b
  • Dermtomyositis – 1b
  • Multiple Sclerosis (Relapse Rate) – 1b
  • Kawasaki – 1a
  • Stiff – Persons syndrome – III

 

For more information, please contact our authorization department at: 1-877-567-8087.